Uncategorized
February 10, 2026 / February 11, 2026 by Dawn Lam
Over the past decade, China has implemented sweeping reforms that dramatically shortened drug development cycles and streamlined clinical trial approvals. A major driver of this acceleration is China’s long-term, innovation-focused policy agenda. Under the 14th and 15th Five‑Year Plans, the government emphasized biological manufacturing, precision medicine, and innovation‑led growth, signaling a shift from infrastructure expansion […]
Read more »
Tagged
December 4, 2025 / January 6, 2026 by Dawn Lam
Next Generation Sequencing (NGS) Grade From synthesis, deprotection and downstream processing, every step is optimized to reduce cross-contamination and mutations to yield oligos with the lowest possible error rates. Therapeutic Grade Whether your therapeutic lead is an aptamer, ASO, siRNA, sgRNA or an Antibody– or Peptide–Oligo Conjugate, we provide the highest levels of purity and […]
Get access to technical content, promotions, upcoming events and press release.
